CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PharmaTimes
Original article

Bespak and SNBL agree global access deal for FDA‑approved nasal device

PartnershipFDA-approved nasal devicePositive
AI Analysis

Summary

Bespak and SNBL have entered into a global access partnership for an FDA-approved nasal device, expanding Bespak's intranasal dry powder capabilities.

Importance:5/10
Sentiment:
0.50
partnershipnasal deviceintranasaldry powderglobal access
Related Companies

Read the original article

Published by PharmaTimes on October 14, 2026 9:42 AM

Read Original